RxEOB Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • RxEOB's estimated annual revenue is currently $1.2M per year.(i)
  • RxEOB's estimated revenue per employee is $87,000

Employee Data

  • RxEOB has 14 Employees.(i)
  • RxEOB grew their employee count by 0% last year.

RxEOB's People

NameTitleEmail/Phone
1
Founder, CEOReveal Email/Phone
2
Operations, Chief Operating OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.1M60%$15.5MN/A
#2
$14.9M103-1%N/AN/A
#3
$339.8M1639-20%N/AN/A
#4
$125.8M694-15%N/AN/A
#5
$112.4M6202%N/AN/A
#6
$33.4M214-23%$21.1MN/A
#7
$23.2M149-12%$21.7MN/A
#8
$43.1M270-10%N/AN/A
#9
$32.7M205-10%N/AN/A
#10
$26.3M165-35%N/AN/A
Add Company

What Is RxEOB?

RxEOB enables health insurers to maximize the value of their pharmacy benefit- using it to effectively reach their members, drive growth, reduce costs, and improve processes across the enterprise. By partnering with RxEOB, your entire organization can leverage pharmacy's timely data and frequent consumer touch points to reduce overall medical and administrative spend; improve measurable care quality; satisfy consumers, providers, and employers alike. With 10 years and 17 million lives of experience, RxEOB brings to each client the unique ability to unravel the complexities of pharmacy data. Just as importantly, we bring extensive expertise in consumer and provider engagement, along with deep libraries of behavior changing tools and content. These capabilities are focused on driving operational transformation across the plan. Rather than replace existing programs, RxEOB technology increases the return on past IT investments, empowering health plans to better partner with their PBMs, employers and consumers and providers in overall health maintenance.

keywords:N/A

N/A

Total Funding

14

Number of Employees

$1.2M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.2M1417%N/A
#2
$1.8M14-50%N/A
#3
$1.2M1417%N/A
#4
$1.7M14N/AN/A
#5
$1.1M140%N/A